A Rare Case of Patient with Left Chilaiditi’s Syndrome

Chilaiditi syndrome asthma obesity case report left side Italy

Authors

  • Marco Umberto Scaramozzino Director Ambulatory of Pulmonology “La Madonnina” Reggio Calabria (RC), Head of Thoracic Endoscopy Villa Aurora Hospital Reggio Calabria (RC), Italy
  • Guido Levi Pulmonology Department, ASST Spedali Civili Brescia, Italy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Italy
  • Ubaldo Romeo Plastina MD, Radiologist in ECORAD Radiology and Ultrasound Study, Reggio Calabria (RC), Italy, Italy
  • Sapone Giovanni Cardiology Department Head of Nursing Polyclinic M.D.C. Reggio Calabria Italy, Italy
Volume (2023)
Case Report
July 28, 2023

Downloads

The following case report aims to highlight the rarity of the case in question, in which there is left Chilaiditi syndrome in a patient with bronchial asthma. The patient is a 79-year-old woman who arrived in January 2023 at my facility for episodes of recurrent dyspnea, chest heaviness, wheezing, eructation, dysphagia, epigastric abdominal pain associated with frequent episodes of bronchitis. He performed simple spirometry which showed mixed mild-moderate ventilatory deficit with reduction of small airway volumes, reduced peak expiratory flow and negative broncho reversibility tests for asthma. At 3 months, the patient returned to my attention with a chest radiograph showing marked elevation of the left hemidiaphragm with deviation of the cardiac shadow to the right. He repeated the spirometry which resulted in a clear improvement compared to the previous control with an important variation of the peak respiratory flow during ICS/LABA, the objective finding previously found disappeared, this indicating the presence of an underlying bronchial asthma. The radiological picture was identified by me as Left Chilaiditi Syndrome, as the patient had gastrointestinal symptoms which accompanied the procession of respiratory symptoms. The diagnostic suspicion must be early in these pathologies and the proton pump inhibitors and new generation alginates with the presence of hyaluronic acid and melatonin must also be included in the treatment of the symptoms, which have an important action on gastroesophageal reflux disease (GERD) secondary to this herniation of the viscera into the thoracic cavity. The rarity is represented by the left localization of the diaphragmatic pathology.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)